Navigation Links
Omnicare and AmerisourceBergen Under Review: Drugs Company Stocks Hit New Highs
Date:2/21/2013

LONDON, February 21, 2013 /PRNewswire/ --

Health-care reforms are expected to bring about paradigm shift in healthcare sectors. However, the major companies are well prepared for such changes. Among others, wholesale drug companies are looking to consolidate their positions in order to be better equipped to face challenges. The stocks are trading on their highs on account of the good performance. AmerisourceBergen Corporation (NYSE: ABC) reported good results and a new collaboration with PharMerica. Similarly, Omnicare Inc. (NYSE: OCR) is getting lapped up Hedge Funds. The stocks are expected to keep up the momentum and perform well. StockCall has released free charting and technical research on these two aforementioned companies. Register to read these reports at

http://www.stockcall.com/report  

AmerisourceBergen Inks Deal with Express Script

AmerisourceBergen's stock hit a new 52-week high. The stock is up 28 percent in the past 52 weeks and seems to maintain the streak. The company also recently announced a 21 cent per share dividend payable on March 4th. Its dividend yield stands at 1.80 percent. AmerisourceBergen reported its fiscal first quarter revenue at $21.5 billion, up 5 percent from $20.3 billion reported a year earlier. Its net income also increased from 62 cents per share to 71 cents apiece. For fiscal 2013, the company expects its earnings to be at $3.16 per share, beating expectations of $3.13 per share. AmerisourceBergen Corporation free technical report can be accessed by signing up at http://www.StockCall.com/ABC022113.pdf  

AmerisourceBergen is expected to keep performing well as the company won a major co
'/>"/>

SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Faruqi & Faruqi, LLP is Investigating AmerisourceBergen Corporation on Behalf of its Shareholders
2. Silver Lining Textiles, Manufacturers of Anti-microbial Under Scrub Garments for the Healthcare Industry, Announces Their Availability Through Amazon.com
3. National Patient Advocate Foundation Supports 340B Drug Discount Program Review Identifying Risks to Underinsured Patients
4. Founder of Nestle-Acquired Company Joins Prismic Pharmaceuticals
5. Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents
6. NewLink Genetics Corporation Announces Exercise of Underwriters Option and Closing of Public Offering of Common Stock
7. Underage Kids Get Hydrocodone Drugs Easily from Family & Friends, Advises New York Center for Living
8. Nearly Half of Children Under 2 Years of Age Receive Some Vaccinations Late
9. Starkey Hearing Foundation Founders Bill and Tani Austin Honored by Dalai Lama After Recent Hearing Mission to India
10. Key patent awarded to Adjuvance co-founders for pioneering method of producing rare vaccine component.
11. PIMCO founder Bill Gross and wife, Sue, make transformational gift to Cedars-Sinais Advanced Health Sciences Pavilion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  Valeant Pharmaceuticals International, ... the closing of its previously announced registered offering of ... (the "Offering"). Pursuant to the Offering, the Company ... per share, for aggregate gross proceeds of approximately $1.45 ... the U.S. Securities and Exchange Commission a final prospectus ...
(Date:3/27/2015)... March 27, 2015 As of February, ... incontinence devices for women. "Shipping thousands ... gratifying part is the hundreds of letters, emails ... lives have been positively impacted by our technology," ... InControl recently released Apex, an over-the-counter ...
(Date:3/27/2015)... , March 27, 2015   Hospira, ... leader in biosimilars and the world,s leading provider ... studies that support an evaluation of biosimilarity of ... Food and Drug Administration (FDA) conditionally approved name ... EPOGEN™ (epoetin alfa). These study data were presented ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
... in Improving Symptoms and Urine Flow, With,Long Lasting ... 23, 2007 /PRNewswire-FirstCall/ -- Spectrum,Pharmaceuticals, Inc., today announced ... Company's drug candidate for the treatment,of benign prostatic ... held at the Anaheim Convention Center in,Anaheim, California ...
... WIRE)--May 23, 2007 - Northfield,Laboratories, Inc. (NASDAQ: ... III trauma trial with PolyHeme(R), its human,hemoglobin-based ... designed to seek an indication for use ... loss when transfusion is,required and red blood ...
Cached Medicine Technology:Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 2Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 3Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 5Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 2Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 3Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 4Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 5Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 6Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 7Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 8
(Date:3/29/2015)... 2015 The Contract Research Organizations ... research, manage data results and help develop and ... regulation standards. Contract research organizations (CROs) mainly serve ... sectors. Industry operators provide clients with a full ... research for Food and Drug Administration (FDA) approval. ...
(Date:3/29/2015)... Franklin, TN (PRWEB) March 29, 2015 ... for several PT Online Continuing Education Courses . ... - 10.0 hours of CME - TPTA, approval # ... Master the evaluation of the shoulder complex - 10.5 ... Course Approved #56400TX , Examination and Treatment of the ...
(Date:3/28/2015)... "Necrorun" was featured on NewsWatch as part of ... latest and coolest applications on the market for iOS, ... and technology expert, conducted the app review and shared ... game with knights, nature, and peasants. , The ... to Eurogamer. The popularity of these games grew over ...
(Date:3/28/2015)... NY (PRWEB) March 28, 2015 Emergency ... offers urgent care in Manhattan, recently commemorated its three-year ... facility in Manhattan. In addition to 24-hour urgent care, ... facilities. , At this time, Emergency Medical Care’s ... abdominal pain, asthma, chest pain, eye injuries, ear infections, ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 One ... re-injury, according to research presented today at the American ... Day. The study examined the long term success of ... , “We examined survey data from 242 patients who ... author Justin P. Roe, MBBS, FRACS, from North Sydney ...
Breaking Medicine News(10 mins):Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 4Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2
... Gardasil, study finds, , TUESDAY, Aug. 18 (HealthDay News) ... a cause of cervical cancer, appears safe, with relatively ... government study. , The study, which included data ... found that the rate of serious adverse events for ...
... ... specializing in healthy and natural dog treats announced today the official launch of its ... for a qualified veterinarian. All licensed U.S. veterinarians may list their practice in ... ...
... BURLINGTON, Mass., Aug. 18 Palomar Medical Technologies, ... developer of light-based systems for cosmetic treatments, announced today that ... confirmed the validity of all claims in the re-examination of ... Removal Using Optical Pulses." , , Rejecting ...
... , OAKLAND, Calif., Aug. 18 The ... Older Adults Maintain Independence: Advancing Technology Adoption," a briefing paper ... chronic health care and increasing the independence of older adults, ... "Spending on hospitalizations and chronic care management now exceeds ...
... , Price of Diabetes Prevention ... , , BETHESDA, Md., Aug. 18 ... with diabetes has been misconstrued during recent health care reform ... nation,s leading professional organization of doctors of podiatric medicine (DPMs), ...
... , , , ... (JCMC), the 488 bed, Magnet-designated flagship hospital of Mountain States Health Alliance (MSHA), ... Smart S q uare , the enterprise scheduling software ... live with Smart Square, JCMC has realized a savings of nearly $550,000 associated ...
Cached Medicine News:Health News:Cervical Cancer Vaccine Seems Safe 2Health News:Cervical Cancer Vaccine Seems Safe 3Health News:FidoDogTreats.com Launches Veterinarian Directory 2Health News:Palomar Successful in U.S. Patent Office Re-Examination of Second Hair Removal Patent 2Health News:Palomar Successful in U.S. Patent Office Re-Examination of Second Hair Removal Patent 3Health News:Palomar Successful in U.S. Patent Office Re-Examination of Second Hair Removal Patent 4Health News:Palomar Successful in U.S. Patent Office Re-Examination of Second Hair Removal Patent 5Health News:Center for Technology and Aging Brief Reviews Technologies That Improve Chronic Care and Help Older Adults Maintain Independence 2Health News:Center for Technology and Aging Brief Reviews Technologies That Improve Chronic Care and Help Older Adults Maintain Independence 3Health News:American Podiatric Medical Association Corrects President's Misstatement on Foot Amputation Costs 2Health News:Johnson City Medical Center Saves $550,000 with Smart Square(R) 2
... immunometric ('sandwich') EIA for the quantitative ... or plasma. LH in the sample ... antibodies directed at different epitopes. One ... and the other is labelled with ...
For the quantitative determination of luteinizing hormone (LH) concentration in human serum....
... a glycoprotein secreted by the anterior pituitary ... the intact LH molecule is a noncovalently-linked ... all have homologous alpha-subunits, however each hormone ... FSH production and secretion are stimulated by ...
Microwell-EIA for the detection of GAD Autoantibody....
Medicine Products: